Lung Cancer ATTRACTION-2 Study: Nivolumab±ipilimumab vs. Placebo for HPD and Natural Disease Progression Mar 29, 2023
Lung Cancer GEMSTONE-301 PHASE III: Sugemalimab vs. Placebo in Chemoradiotherapy Patients Mar 28, 2023
Lung Cancer A Phase 3 Study Investigated Cemiplimab-Induced PROs in aNSCLC Across Regions Mar 14, 2023
Lung Cancer Phase 3 Study: TMB Correlation with Pembrolizumab-Based Chemotherapy Outcomes in NSCLC Mar 14, 2023
